95 related articles for article (PubMed ID: 15899679)
1. Harmonization of the Bayer ADVIA Centaur and Abbott AxSYM automated B-type natriuretic peptide assay in patients on hemodialysis.
Barak M; Weinberger R; Marcusohn J; Froom P
Clin Chem Lab Med; 2005; 43(5):554-6. PubMed ID: 15899679
[TBL] [Abstract][Full Text] [Related]
2. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study.
Wu AH; Packer M; Smith A; Bijou R; Fink D; Mair J; Wallentin L; Johnston N; Feldcamp CS; Haverstick DM; Ahnadi CE; Grant A; Despres N; Bluestein B; Ghani F
Clin Chem; 2004 May; 50(5):867-73. PubMed ID: 15010423
[TBL] [Abstract][Full Text] [Related]
3. Performance characteristics of four automated natriuretic peptide assays.
Rawlins ML; Owen WE; Roberts WL
Am J Clin Pathol; 2005 Mar; 123(3):439-45. PubMed ID: 15716241
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determination.
Haltmayer M; Mueller T; Gegenhuber A; Poelz W
Clin Lab; 2004; 50(3-4):175-80. PubMed ID: 15074472
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
Taylor P; Pickard G; Gammie A; Atkins M
J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
[TBL] [Abstract][Full Text] [Related]
6. Performance of a new HIV 1/O/2 assay on the Bayer ADVIA Centaur immunoassay system.
van Helden J; Denoyel G; Freeman J; Preisel-Simmons B
Clin Lab; 2004; 50(1-2):83-90. PubMed ID: 15000224
[TBL] [Abstract][Full Text] [Related]
7. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
[TBL] [Abstract][Full Text] [Related]
8. Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method.
Storti S; Prontera C; Emdin M; Passino C; Prati P; Fontani G; Giannelli I; Zyw L; Vittorini S; Zucchelli G; Clerico A
Clin Chem Lab Med; 2004; 42(10):1178-85. PubMed ID: 15552278
[TBL] [Abstract][Full Text] [Related]
9. Performance evaluation of the ADVIA Centaur anti-HBe and HBeAg assays.
van Helden J; Cornely C; Dati F; Levy HR; Bal T; Seeger M; Wright T; Baker L
J Clin Virol; 2008 Oct; 43(2):169-75. PubMed ID: 18635392
[TBL] [Abstract][Full Text] [Related]
10. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
[TBL] [Abstract][Full Text] [Related]
11. Performance characteristics of the Architect brain natriuretic peptide (BNP) assay: a two site study.
Mongia SK; La'ulu SL; Apple FS; Ler R; Murakami MM; Roberts WL
Clin Chim Acta; 2008 May; 391(1-2):102-5. PubMed ID: 18294456
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the analytical performance characteristics of the Bayer ACS:180 B-type natriuretic peptide (BNP) assay.
Wians FH; Wilson BA; Grant A; Bailey J; Gheorghiu I; Conarpe C; Mindicino H; Thakur K; Belenky A; Despres N; Bluestein B
Clin Chim Acta; 2005 Mar; 353(1-2):147-55. PubMed ID: 15698602
[TBL] [Abstract][Full Text] [Related]
13. Preliminary evaluation of the AxSYM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay.
Mueller T; Gegenhuber A; Poelz W; Haltmayer M
Clin Chem; 2004 Jun; 50(6):1104-6. PubMed ID: 15161739
[No Abstract] [Full Text] [Related]
14. Comparison of automated insulin assays.
Vogeser M; Parhofer KG
Clin Lab; 2007; 53(9-12):557-60. PubMed ID: 18257460
[TBL] [Abstract][Full Text] [Related]
15. Analytical performances and heart failure research of the BNP and NT-proBNP assays on the Cobas E601 and ADVIA Centaur.
Zhang X; Wang W; Wang Q; Yang Y; Wen D; Yang Z; Lan H; Li F; Ouyang N; Kan L; Suo M; Yan H
Clin Lab; 2013; 59(7-8):715-25. PubMed ID: 24133898
[TBL] [Abstract][Full Text] [Related]
16. Performance of a new hepatitis C assay on the Bayer ADVIA Centaur Immunoassay System.
Denoyel G; van Helden J; Bauer R; Preisel-Simmons B
Clin Lab; 2004; 50(1-2):75-82. PubMed ID: 15000223
[TBL] [Abstract][Full Text] [Related]
17. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
[TBL] [Abstract][Full Text] [Related]
18. Influence of sample matrix and storage on BNP measurement on the Bayer Advia Centaur.
Lippi G; Fortunato A; Salvagno GL; Montagnana M; Soffiati G; Guidi GC
J Clin Lab Anal; 2007; 21(5):293-7. PubMed ID: 17847103
[TBL] [Abstract][Full Text] [Related]
19. European performance evaluations of the ADVIA Centaur infectious disease assays: requirements for performance evaluation according to the European directive on in vitro diagnostics.
Dati F; Denoyel G; van Helden J
J Clin Virol; 2004 Apr; 30 Suppl 1():S6-10. PubMed ID: 15062761
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the diagnostic characteristics of two B-type natriuretic peptide point-of-care devices.
Ro R; Thode HC; Taylor M; Gulla J; Tetrault E; Singer AJ
J Emerg Med; 2011 Dec; 41(6):661-7. PubMed ID: 21620610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
